Key Events This Week
16 Mar: New 52-week low at Rs.9.3
19 Mar: Valuation parameters upgraded to very attractive
20 Mar: Week closes at Rs.9.40 (-3.09%)

Gennex Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-03-19 08:00:35Gennex Laboratories Ltd has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a challenging recent performance relative to the broader market. This change is underpinned by improved price-to-earnings and price-to-book value ratios, positioning the micro-cap pharmaceutical player as a compelling consideration within its sector.
Read full news article
Gennex Laboratories Ltd Stock Hits 52-Week Low at Rs.9.3
2026-03-16 11:32:38Gennex Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a fresh 52-week low of Rs.9.3 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics.
Read full news article
Gennex Laboratories Ltd Stock Falls to 52-Week Low of Rs.9.61
2026-03-13 19:59:59Gennex Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.9.61 today, marking a significant decline amid broader market weakness and sectoral underperformance.
Read full news article
Gennex Laboratories Ltd Stock Falls to 52-Week Low of Rs.9.9
2026-03-12 14:55:51Gennex Laboratories Ltd’s stock declined to a fresh 52-week low of Rs.9.9 on 12 Mar 2026, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector and broader market weakness. The stock underperformed its sector and key indices, continuing a downward trend that has persisted over the past year.
Read full news article
Gennex Laboratories Ltd is Rated Sell
2026-03-11 10:10:03Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Gennex Laboratories Ltd Stock Hits 52-Week Low at Rs.9.92
2026-03-10 13:18:08Gennex Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.9.92 today, marking a significant decline amid broader market fluctuations and sectoral underperformance.
Read full news article
Gennex Laboratories Ltd Stock Hits 52-Week Low at Rs.10.1
2026-03-09 13:32:39Gennex Laboratories Ltd’s shares declined sharply to a new 52-week low of Rs.10.1 on 9 March 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns. The stock has underperformed its sector and the broader market over the past year, reflecting a challenging period for the pharmaceutical and biotechnology firm.
Read full news article






